Dr. Elias Traboulsi, a pediatric ophthalmologist, said the vision challenges associated with neurofibromatosis type 1 (NF1) and type 2 (NF2) this week.

These ocular complications are significant because the genetic conditions can cause optic pathway tumors and other manifestations that impair both vision and visual-learning development.

Speaking at the Neurofibromatosis Symposium hosted by Cleveland Clinic, Traboulsi said how these conditions affect the eyes. NF1 is a genetic condition that affects the skin, nervous system, and other parts of the body, according to Everyday Health.

The prevalence of NF1 is approximately one in 5,000 people [1]. While the condition is often associated with childhood development, vision loss can persist or emerge in older adults. One case report described a 75-year-old man [2] who presented with loss of vision in the right eye alongside classic developmental changes of NF1.

Clinical heterogeneity is a hallmark of the disease. Experts said that NF1 and NF2 exhibit variations in neurocognitive impacts, though the psychosocial impact of the conditions is more universal.

Because these genetic conditions cause tumors that can obstruct the optic pathway, early detection and specialized ophthalmological care are critical for maintaining quality of life. The symposium emphasized the intersection of ocular health, and the broader systemic effects of neurofibromatosis.

“Neurofibromatosis type 1 (NF1) is a genetic condition that affects the skin, nervous system, and other parts of the body.”

The connection between neurofibromatosis and vision loss underscores the necessity of multidisciplinary care. Because NF1 and NF2 are systemic genetic disorders, ocular manifestations are not isolated incidents but symptoms of broader neurological risks, meaning regular screenings are essential to prevent permanent visual impairment and support cognitive development in children.